Articles related to GUIDELINES/RECOMMENDATIONS

Recent guidelines emphasize four primary medication classes for hypertension management, steering away from older options that may carry higher risks of side effects.

The 2024 guideline introduces a more nuanced approach to preoperative stress testing and anticoagulation management, potentially reducing unnecessary testing and complications.

The Endocrine Society’s 2024 guidelines suggest against routine vitamin D screening and supplementation for most adults under 75, marking a significant shift in clinical practice recommendations.

The FDA’s new mandate requires all mammography facilities to inform women about their breast density, recognizing its significance in cancer risk and detection challenges.

The PREVENT equation, developed by the American Heart Association in 2023, aims to provide a more accurate cardiovascular risk assessment for today’s population, potentially reducing statin prescriptions by 40%.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.